Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Correction for Fukuda et al., Conditional Transgenic System for Mouse Aurora A Kinase: Degradation by the Ubiquitin Proteasome Pathway Controls the Level of the Transgenic Protein.

Fukuda T, Mishina Y, Walker MP, DiAugustine RP.

Mol Cell Biol. 2015 Dec;35(23):4094. doi: 10.1128/MCB.00735-15. No abstract available.

2.

An IGF1/insulin receptor substrate-1 pathway stimulates a mitotic kinase (cdk1) in the uterine epithelium during the proliferative response to estradiol.

Walker MP, Diaugustine RP, Zeringue E, Bunger MK, Schmitt M, Archer TK, Richards RG.

J Endocrinol. 2010 Nov;207(2):225-35. doi: 10.1677/JOE-10-0102. Epub 2010 Aug 26.

3.

Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.

Schmitt M, Walker MP, Richards RG, Bocchinfuso WP, Fukuda T, Medina D, Kittrell FS, Korach KS, DiAugustine RP.

Mol Carcinog. 2006 Jul;45(7):490-505.

PMID:
16482517
5.
6.

Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.

Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE.

J Biol Chem. 2004 Feb 20;279(8):6883-92. Epub 2003 Dec 8.

8.

Myelination is altered in insulin-like growth factor-I null mutant mice.

Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ.

J Neurosci. 2002 Jul 15;22(14):6041-51.

9.

Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells.

Oh JS, Kucab JE, Bushel PR, Martin K, Bennett L, Collins J, DiAugustine RP, Barrett JC, Afshari CA, Dunn SE.

Neoplasia. 2002 May-Jun;4(3):204-17.

10.

Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.

Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS.

J Biol Chem. 2002 Mar 8;277(10):8531-7. Epub 2001 Dec 21.

11.

E2-induced degradation of uterine insulin receptor substrate-2: requirement for an IGF-I-stimulated, proteasome-dependent pathway.

Richards RG, Klotz DM, Bush MR, Walmer DK, DiAugustine RP.

Endocrinology. 2001 Sep;142(9):3842-9.

PMID:
11517161
12.

Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations.

Newbold RR, DiAugustine RP, Risinger JI, Everitt JI, Walmer DK, Parrott EC, Dixon D.

Environ Health Perspect. 2000 Oct;108 Suppl 5:769-73. Review.

PMID:
11035980
13.
14.

Synthesis and properties of an EGF-like domain (residues 361-406) in the extreme N-terminal region of the mouse EGF precursor.

Diaugustine RP, Henry R, Sewall CH, Suarez-Quian CA, Walker MP.

Growth Factors. 1999;17(1):37-48.

PMID:
10495961
15.

Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.

Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, Hom YK, Cunha GR, DiAugustine RP.

Cell Growth Differ. 1998 Sep;9(9):777-85.

16.
17.

The mouse estrogen receptor-related orphan receptor alpha 1: molecular cloning and estrogen responsiveness.

Shigeta H, Zuo W, Yang N, DiAugustine R, Teng CT.

J Mol Endocrinol. 1997 Dec;19(3):299-309.

PMID:
9460651
18.

EGF-related peptides and their receptors in mammary gland development.

DiAugustine RP, Richards RG, Sebastian J.

J Mammary Gland Biol Neoplasia. 1997 Apr;2(2):109-17. Review.

PMID:
10882297
19.

Expression of a prolactin-like factor in preneoplastic and neoplastic mouse mammary gland and cells.

Jahnke GD, Trempus CS, Kari FW, DiAugustine RP.

J Mol Endocrinol. 1996 Dec;17(3):247-56.

PMID:
8981231
20.

Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.

Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12626-30.

21.

Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus.

Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):12002-7.

22.

Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.

Snedeker SM, Diaugustine RP.

Prog Clin Biol Res. 1996;394:211-53. Review.

PMID:
8778798
23.

Immunoblot studies of the IGF-related acid-labile subunit.

Liu F, Hintz RL, Khare A, Diaugustine RP, Powell DR, Lee PD.

J Clin Endocrinol Metab. 1994 Dec;79(6):1883-6.

PMID:
7527417
24.
25.

Transgenic approaches for modifying the mammary gland to produce therapeutic proteins.

Romagnolo D, DiAugustine RP.

Environ Health Perspect. 1994 Oct;102(10):846-51. Review.

26.

The mammary gland: protein factory of the future.

Romagnolo D, DiAugustine RP.

Environ Health Perspect. 1994 Aug;102(8):644-6. No abstract available.

27.

Expression of epidermal growth factor in suprabasal cells of stratified squamous epithelia: implications for a role in differentiation.

Sakai Y, Nelson KG, Snedeker S, Bossert NL, Walker MP, McLachlan J, DiAugustine RP.

Cell Growth Differ. 1994 May;5(5):527-35.

28.

The epidermal growth factor family in the mammary gland and other target organs for ovarian steroids.

DiAugustine RP.

Cancer Treat Res. 1994;71:131-60. Review. No abstract available.

PMID:
7946946
29.

Characterization of epidermal growth factor in mouse testis.

Radhakrishnan B, Oke BO, Papadopoulos V, DiAugustine RP, Suarez-Quian CA.

Endocrinology. 1992 Dec;131(6):3091-9.

PMID:
1446643
30.

32P-postlabeling analysis of the formation and persistence of DNA adducts in mammary glands of parous and nulliparous mice treated with benzo[a]pyrene.

Walker MP, Jahnke GD, Snedeker SM, Gladen BC, Lucier GW, DiAugustine RP.

Carcinogenesis. 1992 Nov;13(11):2009-15.

PMID:
1423869
31.

Epidermal growth factor dependence and TGF alpha autocrine growth regulation in primary rat tracheal epithelial cells.

Ferriola PC, Robertson AT, Rusnak DW, Diaugustine R, Nettesheim P.

J Cell Physiol. 1992 Aug;152(2):302-9.

PMID:
1639864
32.
33.

Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis.

Jahnke GD, Thompson CL, Walker MP, Gallagher JE, Lucier GW, DiAugustine RP.

Carcinogenesis. 1990 Feb;11(2):205-11.

PMID:
2105856
34.

Epidermal growth factor precursor in mouse lactating mammary gland alveolar cells.

Brown CF, Teng CT, Pentecost BT, DiAugustine RP.

Mol Endocrinol. 1989 Jul;3(7):1077-83.

PMID:
2477693
35.

Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid.

DiAugustine RP, Petrusz P, Bell GI, Brown CF, Korach KS, McLachlan JA, Teng CT.

Endocrinology. 1988 Jun;122(6):2355-63.

PMID:
3286224
36.

Evidence for isoaspartyl (deamidated) forms of mouse epidermal growth factor.

DiAugustine RP, Gibson BW, Aberth W, Kelly M, Ferrua CM, Tomooka Y, Brown CF, Walker M.

Anal Biochem. 1987 Sep;165(2):420-9.

PMID:
3501256
37.

Evaluation of murine placental degradation and transfer of [125I]iodo-epidermal growth factor.

DiAugustine RP, Rosch MJ, Lannon DE, Walker MP, Pratt RM.

Endocrinology. 1987 Mar;120(3):1190-200.

PMID:
3492368
38.

Purification and properties of an oestrogen-stimulated mouse uterine glycoprotein (approx. 70 kDa).

Teng CT, Walker MP, Bhattacharyya SN, Klapper DG, DiAugustine RP, McLachlan JA.

Biochem J. 1986 Dec 1;240(2):413-22.

39.

Proliferation of mouse uterine epithelial cells in vitro.

Tomooka Y, DiAugustine RP, McLachlan JA.

Endocrinology. 1986 Mar;118(3):1011-8.

PMID:
3004888
40.

Beta-epidermal growth factor is the des-asparaginyl form of the polypeptide.

DiAugustine RP, Walker MP, Klapper DG, Grove RI, Willis WD, Harvan DJ, Hernandez O.

J Biol Chem. 1985 Mar 10;260(5):2807-11.

41.

Neuroendocrinelike (small granule) epithelial cells of the lung.

DiAugustine RP, Sonstegard KS.

Environ Health Perspect. 1984 Apr;55:271-95. Review.

42.

Adrenocorticotropin radioimmunoassay: properties of antisera against synthetic ACTH(1-24) and its clinical application.

Khan MN, Mirel RD, Ontjes DA, Ghosh AP, Lazarus LH, DiAugustine RP.

Horm Res. 1984;20(2):129-37.

PMID:
6092254
43.

"Joining peptide" of pro-opiomelanocortin. II. Interspecies heterogeneity of the joining peptide fragment.

Jahnke GD, Soldato CM, Erisman MD, DiAugustine RP, Lazarus LH.

Peptides. 1983 Jul-Aug;4(4):483-92.

PMID:
6647118
44.

"Joining peptide" of pro-opiomelanocortin. I. Radioimmunoassay and extraction of related peptides from pituitary glands.

Erisman MD, Lazarus LH, Jahnke GD, Soldato CM, DiAugustine RP.

Peptides. 1983 Jul-Aug;4(4):475-82.

PMID:
6647117
45.

Physalaemin: an amphibian tachykinin in human lung small-cell carcinoma.

Lazarus LH, DiAugustine RP, Jahnke GD, Hernandez O.

Science. 1983 Jan 7;219(4580):79-81.

PMID:
6294828
46.

A substance with immunoreactivity to the peptide physalaemin in mammalian respiratory tissue.

Lazarus LH, DiAugustine RP, Soldato CM.

Exp Lung Res. 1982 Nov;3(3-4):329-41.

PMID:
7169058
47.

Morphological and cytochemical characterization of neuroepithelial bodies in fetal rabbit lung. I. Studies of isolated neuroepithelial bodies.

Sonstegard KS, Mailman RB, Cheek JM, Tomlin TE, DiAugustine RP.

Exp Lung Res. 1982 Nov;3(3-4):349-77.

PMID:
6132813
48.

Human lung small-cell carcinoma contains bombesin.

Erisman MD, Linnoila RI, Hernandez O, DiAugustine RP, Lazarus LH.

Proc Natl Acad Sci U S A. 1982 Apr;79(7):2379-83.

49.

Lung endocrine-like cells in hamsters treated with diethylnitrosamine: alterations in vivo and in cell culture.

Linnoila RI, Nettesheim P, DiAugustine RP.

Proc Natl Acad Sci U S A. 1981 Aug;78(8):5170-4.

50.

Peptide hormone degradation by a rat mast cell chymase-heparin complex.

Jahnke GD, Lazarus LH, DiAugustine RP, Soldato CM, Erisman MD.

Life Sci. 1981 Jul 27;29(4):397-403. No abstract available.

PMID:
6268912

Supplemental Content

Loading ...
Support Center